References
- Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3:1. doi: 10.1186/s40733-016-0029-3.
- Centers for Disease Control and Prevention. Most Recent Asthma Data 2018 (updated May 2018). Available from: https://www.cdc.gov/asthma/most_recent_data.htm.
- Sullivan PW, Ghushchyan VH, Slejko JF, Belozeroff V, Globe DR, Lin SL. The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol. 2011;127:363–369 e1-3. doi: 10.1016/j.jaci.2010.10.042.
- Sullivan PW, Slejko JF, Ghushchyan VH, Sucher B, Globe DR, Lin S-L, Globe G, et al. The relationship between asthma, asthma control and economic outcomes in the United States. J Asthma. 2014;51:769–778. doi: 10.3109/02770903.2014.906607.
- Sullivan PW, Campbell JD, Globe G, Ghushchyan VH, Bender B, Schatz M, Chon Y, et al. Measuring the effect of asthma control on exacerbations and health resource use. J Allergy Clin Immunol. 2015;136:1409–1411. e1-6. doi: 10.1016/j.jaci.2015.04.046.
- Sullivan PW, Ghushchyan VH, Campbell JD, Globe G, Bender B, Magid DJ. Measuring the cost of poor asthma control and exacerbations. J Asthma. 2017;54:24–31. doi: 10.1080/02770903.2016.1194430.
- Chen H, Blanc PD, Hayden ML, Bleecker ER, Chawla A, Lee JH. Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma. Value Health. 2008;11:231–239. doi: 10.1111/j.1524-4733.2007.00229.x.
- Knudsen TB, Thomsen SF, Nolte H, Backer V. A population-based clinical study of allergic and non-allergic asthma. J Asthma. 2009;46:91–94. doi: 10.1080/02770900802524657.
- Lafeuille MH, Gravel J, Figliomeni M, Zhang J, Lefebvre P. Burden of illness of patients with allergic asthma versus non-allergic asthma. J Asthma. 2013;50:900–907. doi: 10.3109/02770903.2013.810244.
- Edwards MR, Saglani S, Schwarze J, Skevaki C, Smith JA, Ainsworth B, Almond M, et al. Addressing unmet needs in understanding asthma mechanisms. From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators. Eur Respir J. 2017;49:1602448. doi: 10.1183/13993003.02448-2016.
- Samitas K, Carter A, Kariyawasam HH, Xanthou G. Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited. Allergy. 2018;73:993–1002. doi: 10.1111/all.13373.
- Bousquet J, Gaugris S, Kocevar VS, Zhang Q, Yin DD, Polos PG, Bjermer L, et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the improving asthma control trial. Clin Exp Allergy. 2005;35:723–727. doi: 10.1111/j.1365-2222.2005.02251.x.
- Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy. 2005;35:282–287. doi: 10.1111/j.1365-2222.2005.02182.x.
- Thomas M. Allergic rhinitis: evidence for impact on asthma. BMC Pulm Med. 2006;6:S4. doi: 10.1186/1471-2466-6-S1-S4.
- Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol. 2002;109:636–642. doi: 10.1067/mai.2002.123237.
- Corren J, Manning BE, Thompson SF, Hennessy S, Strom BL. Rhinitis therapy and the prevention of hospital care for asthma: A case-control study. J Allergy Clin Immunol. 2004;113:415–419. doi: 10.1016/j.jaci.2003.11.034.
- Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: The risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol. 2002;109:57–62. doi: 10.1067/mai.2002.120554.
- Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention (2018 update); 2018. Available at: http://www.ginasthma.org. Accessed May 16, 2019.
- Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, Brignardello-Petersen R, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140:950–958. doi: 10.1016/j.jaci.2017.03.050.
- Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353–365. doi: 10.2165/00019053-199304050-00006.
- Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4:e297. doi: 10.1371/journal.pmed.0040297.
- Lee LK, Obi E, Paknis B, Kavati A, Chipps B. Asthma control and disease burden in patients with asthma and allergic comorbidities. J Asthma. 2018;55:208–219. doi: 10.1080/02770903.2017.1316394.